DOCSLIB.ORG

The Ubiquitin System and Deubiquitinating Enzyme USP25

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Ubiquitin System and Deubiquitinating Enzyme USP25 ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi doctoral i la seva utilització ha de respectar els drets de la persona autora. Pot ser utilitzada per a consulta o estudi personal, així com en activitats o materials dʼinvestigació i docència en els termes establerts a lʼart. 32 del Text Refós de la Llei de Propietat Intel·lectual (RDL 1/1996). Per altres utilitzacions es requereix lʼautorització prèvia i expressa de la persona autora. En qualsevol cas, en la utilització dels seus continguts caldrà indicar de forma clara el nom i cognoms de la persona autora i el títol de la tesi doctoral. No sʼautoritza la seva reproducció o altres formes dʼexplotació efectuades amb finalitats de lucre ni la seva comunicació pública des dʼun lloc aliè al servei TDX. Tampoc sʼautoritza la presentació del seu contingut en una finestra o marc aliè a TDX (framing). Aquesta reserva de drets afecta tant als continguts de la tesi com als seus resums i índexs. ADVERTENCIA. El acceso a los contenidos de esta tesis doctoral y su utilización debe respetar los derechos de la persona autora. Puede ser utilizada para consulta o estudio personal, así como en actividades o materiales de investigación y docencia en los términos establecidos en el art. 32 del Texto Refundido de la Ley de Propiedad Intelectual (RDL 1/1996). Para otros usos se requiere la autorización previa y expresa de la persona autora. En cualquier caso, en la utilización de sus contenidos se deberá indicar de forma clara el nombre y apellidos de la persona autora y el título de la tesis doctoral. No se autoriza su reproducción u otras formas de explotación efectuadas con fines lucrativos ni su comunicación pública desde un sitio ajeno al servicio TDR. Tampoco se autoriza la presentación de su contenido en una ventana o marco ajeno a TDR (framing). Esta reserva de derechos afecta tanto al contenido de la tesis como a sus resúmenes e índices. WARNING. The access to the contents of this doctoral thesis and its use must respect the rights of the author. It can be used for reference or private study, as well as research and learning activities or materials in the terms established by the 32nd article of the Spanish Consolidated Copyright Act (RDL 1/1996). Express and previous authorization of the author is required for any other uses. In any case, when using its content, full name of the author and title of the thesis must be clearly indicated. Reproduction or other forms of for profit use or public communication from outside TDX service is not allowed. Presentation of its content in a window or frame external to TDX (framing) is not authorized either. These rights affect both the content of the thesis and its abstracts and indexes. Structure insights into the autoinhibitory mechanism of the deubiquitinating enzyme USP25 and into the SUMO E1-E2 protein-protein recognition Bing Liu Supervisor: Dr. David Reverter A thesis submitted for the degree of Biochemistry and Molecular Biology Universitat Autònoma de Barcelona Institut de Biotecnologia i de Biomedicina (IBB) September 2018 The pursuit of science needs special courage Acknowledgements First of all, I would like to thank my mother and sisters for their love and support at every moment, despite a distance of ten thousand kilometers away. To my mother, I know you have been worried about my lives in Barcelona. I apologize that I cannot take care of you these years, albeit you never complain about that. To my two sisters, I thank you for the kindly help on my lives. I also would like to thank my girlfriend for your support when I was feeling frustrated and helpless and for the wonderful time we had together. To my supervisor, David Reverter, I would like to sincerely thank you for your best training on my scientific research. Your knowledge and ideas of science always inspire me, and your patient guide let me have a glimpse into the beauty of protein structure at the first time. I would like to thank my lab mates, Natalia, Jara, Pablo, Zhen, as well as members from our neighbor group, for your kindly help and discussion on my research. I am also thankful to members of the other groups in IBB, for the help on the lab work. I would like to thank Maria Lois from CRAG-UAB, Marta Sureda-Gómez and Virginia Amador from IDIBAPS, for their direct contributions on my research publications. Finally, thanks to Chinese Scholarship Council (CSC) grant for supporting my PhD study. Bing Liu September 2018 Index Introduction………...……………………………………………....….1 The ubiquitin system and deubiquitinating enzyme USP25….……….….….3 The SUMO system and E1-E2 protein-protein recognition…...………...….17 USP25 in the cross talk of ubiquitin and SUMO pathways……………..…..23 Research objectives………..…………….……………………………..…..35 Chapter 1: A quaternary tetramer assembly inhibits the deubiquitinating activity of USP25…………………………...41 Chapter 2: Structural analysis and evolution of specificity of the SUMO UFD E1-E2 interactions………………………93 Chapter 3: Structure insights into specificities of SUMO E1-E2 interactions between A. thaliana and human………………125 General conclusions ………………...…………………………….………165 General discussion……………………………..………………….….…...171 Summary in English…………………..………………………..…………..181 Summary in Catalán…………………..……...…………………………….185 Introduction 1 2 The ubiquitin system and deubiquitinating enzyme USP25 Post-translational modifications increase protein complexity While it is estimated that human genome encodes 20,000-25,000 protein- coding genes (1), the total number of proteins in human proteome is estimated to be many times more, possibly ranging from 10,000 to almost 1 million. This is because a single gene can generate different variants of a particular protein through, for example, alternative splicing, mRNA editing, and genomic recombination. The complexity of human proteome is further increased by protein post-translational modifications (PTMs), including phosphorylation, glycosylation, lipidation, carbonylation, acetylation, methylation, and ubiquitination. These mechanisms can somehow explain why humans could be so much more complex with just 25,000 genes. Figure 1. A view of post-translational modifications from protein complexity (2). Ubiquitin and ubiquitination In the late 1970s and 1980s, Avram Hershko, Aaron Ciechanover and Irwin Rose discovered and characterized the ATP-dependent, ubiquitin-mediated proteolysis. As a result of their pioneering studies, they were awarded with the 2004 Nobel Prize in Chemistry (3). After the landmark discovery of ubiquitin-mediated degradation by the 26S proteasome, the protein-based modifications became 3 prevalent. Today, it is quite clear that this function of ubiquitin was just the tip of an enormous iceberg. The recent global proteomic studies provide insight into the complexity of the ubiquitin system and about 1.3% of total cellular proteins are substrates of ubiquitination in human cells (4). In human societies, people communicate with each other using words and sentences that can trigger specific responses from other individuals. Similarly, proteins are modified with polymeric ubiquitin chains, in which the linkage between ubiquitin molecules encodes information. Thus, ubiquitin code is like the communication language between and within cells and determinates the fate of its substrate. The ubiquitin system is a universal means of protein regulation which controls a wide range of cellular processes including gene transcription, cell cycle, cell death, signal transduction, DNA repair, and autophagy (5-10). Worth of the name, ubiquitin is quite ubiquitous in biology. Ubiquitin (Ub) is a highly conserved 76-residue protein (~8.5 kDa) that is present in all eukaryotes, from yeast to human. In human genome, there are four genes coding for ubiquitin: UBB, UBC, UBA52, and RPS27A (11). Ubiquitin-like proteins (Ubls) are a set of proteins which adopt the same β-grasp fold as ubiquitin. As one of the most known protein posttranslational modifiers, ubiquitin and Ubls are covalently attached to an ε-amino group of the substrate protein’s lysine residues (Figure 2). This modification is carried out via a conserved three-step enzymatic cascade through the E1 activating enzyme, the E2 conjugation enzyme, and E3 protein ligase, resulting the formation of an isopeptide bond between the C terminus of ubiquitin and the lysine on the target protein (5, 12). First, E1 activates the C-terminal glycine residue of ubiquitin in an ATP-dependent manner, resulting in the formation of an intermediate ubiquitin adenylate, followed by the binding of the C-terminus of ubiquitin to the active cysteine residue of E1 through a thioester linkage. Second, the activated ubiquitin is transferred from E1 to E2, whose active cysteine residue forms a thioester bond with the C-terminus of ubiquitin. Finally, E3 ligase interacts with ubiquitin-loaded E2 and mediates the final ubiquitin transfer, forming an isopeptide bond between the lysine ε-amino group of the target protein and the C-terminal carboxyl group of ubiquitin. In addition, ubiquitin can also be attached on N-terminus amino group, cysteine, serine, and threonine residues of the target proteins (13-17). 4 Figure 2. Ubl conjugation and deconjugation pathways (10). Precursor Ubls (including ubiquitin) are processed by either DUBs (deubiquitinating enzymes) or ULPs (Ubl-specific proteases) to expose a C-terminal glycine in the mature Ubl. The processed Ubl is conjugated to the target protein via a three-step enzymatic cascade through the E1 activating enzyme, E2 conjugation enzyme, and E3 protein ligase. The DUBs and ULPs can remove Ubls from substrates. Ubiquitination enzymes Specificity of ubiquitination to the thousands of human substrates depends on the sequential action of E1s, E2s, and E3s. There are 2 E1s, ~40 E2s, and more than 600 E3s in human ubiquitin system (18-23). E2s play the dominant role in the ubiquitin chain assembly. E3s are the most heterogeneous and critical components in the ubiquitination cascade, as they bind directly to their target proteins and strictly control the efficiency and specificity of the ubiquitination reaction (21).
Load more

Recommended publications
  • "Hsp70 Chaperones"
    Hsp70 Chaperones Advanced article Elizabeth A Craig, University of Wisconsin, Madison, Wisconsin, USA Article Contents . Introduction Jaroslaw Marszalek, University of Gdansk, Gdansk, Poland . Hsp70:Client Protein Interaction Cycle . Proliferation of Hsp70 and J-protein Genes . Function and Evolution of Mitochondrial Hsp70 Systems . Conclusions: Versatility of Hsp70 System Allows for Adaptation to New Functions Online posting date: 15th March 2011 Via their interaction with client proteins, Hsp70 molecu- stress. In some cases they also facilitate transfer of client lar chaperone machines function in a variety of cellular proteins to proteolytic systems, particularly when refolding processes, including protein folding, translocation of into the native state is unachievable. See also: Chaperones, proteins across membranes and assembly/disassembly of Chaperonin and Heat-Shock Proteins The ability of Hsp70 chaperones to be involved in such protein complexes. Such machines are composed of a core diverse cellular functions, whereas relying on a single bio- Hsp70, as well as a J-protein and a nucleotide exchange chemical activity, an adenosine triphosphate (ATP)- factor as co-chaperones. These co-factors regulate the dependent client binding and release cycle, is remarkable. cycle of adenosine triphosphate (ATP) hydrolysis and Here, to illustrate the molecular mechanisms and evo- nucleotide exchange, which is critical for Hsp70’s inter- lutionary history behind the specialisation of Hsp70 sys- action with client proteins. Cellular compartments often tems we focus on mitochondrial Hsp70 systems, as they contain multiple Hsp70s, J-proteins and nucleotide exemplify two major strategies of Hsp70 specialisation: exchange factors. The capabilities of Hsp70s to carry out (i) amplification and diversification of HSP70 genes and diverse cellular functions can result from either special- (ii) multiplication and specialisation of genes encoding isation of an Hsp70 or by interaction of a multifunctional their J-proteins co-chaperones (Figure 1).
    [Show full text]
  • Chr21 Protein-Protein Interactions: Enrichment in Products Involved in Intellectual Disabilities, Autism and Late Onset Alzheimer Disease
    bioRxiv preprint doi: https://doi.org/10.1101/2019.12.11.872606; this version posted December 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Chr21 protein-protein interactions: enrichment in products involved in intellectual disabilities, autism and Late Onset Alzheimer Disease Julia Viard1,2*, Yann Loe-Mie1*, Rachel Daudin1, Malik Khelfaoui1, Christine Plancon2, Anne Boland2, Francisco Tejedor3, Richard L. Huganir4, Eunjoon Kim5, Makoto Kinoshita6, Guofa Liu7, Volker Haucke8, Thomas Moncion9, Eugene Yu10, Valérie Hindie9, Henri Bléhaut11, Clotilde Mircher12, Yann Herault13,14,15,16,17, Jean-François Deleuze2, Jean- Christophe Rain9, Michel Simonneau1, 18, 19, 20** and Aude-Marie Lepagnol- Bestel1** 1 Centre Psychiatrie & Neurosciences, INSERM U894, 75014 Paris, France 2 Laboratoire de génomique fonctionnelle, CNG, CEA, Evry 3 Instituto de Neurociencias CSIC-UMH, Universidad Miguel Hernandez-Campus de San Juan 03550 San Juan (Alicante), Spain 4 Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA 5 Center for Synaptic Brain Dysfunctions, Institute for Basic Science, Daejeon 34141, Republic of Korea 6 Department of Molecular Biology, Division of Biological Science, Nagoya University Graduate School of Science, Furo, Chikusa, Nagoya, Japan 7 Department of Biological Sciences, University of Toledo, Toledo, OH, 43606, USA 8 Leibniz Forschungsinstitut für Molekulare Pharmakologie
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • Identifying SUMO Protease Targets and Investigating E3 Ligase Interactions
    W&M ScholarWorks Dissertations, Theses, and Masters Projects Theses, Dissertations, & Master Projects 2014 Identifying SUMO Protease Targets and Investigating E3 Ligase Interactions Mark Guillotte College of William & Mary - Arts & Sciences Follow this and additional works at: https://scholarworks.wm.edu/etd Part of the Molecular Biology Commons Recommended Citation Guillotte, Mark, "Identifying SUMO Protease Targets and Investigating E3 Ligase Interactions" (2014). Dissertations, Theses, and Masters Projects. Paper 1539626956. https://dx.doi.org/doi:10.21220/s2-wrgj-tz43 This Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Dissertations, Theses, and Masters Projects by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. Identifying SUMO protease targets and investigating E3 ligase interactions Mark Guillotte Baton Rouge, Louisiana Bachelors of Science, Louisiana State University, 2010 A Thesis presented to the Graduate Faculty of the College of William and Mary in Candidacy for the Degree of Master of Science Department of Biology The College of William and Mary January 2014 APPROVAL PAGE This Thesis is submitted in partial fulfillment of the requirements for the degree of Master of Science Mark Guillotte Approved by^he Committee, January 2014 (be Chair Associate Professor Oliver Kerseher, Biology The College of William and Mary ' oVY wG ..G S l1m>. rofessor Lizabeth Allison, Biology The College of William and Mary Professor Diane Shakes, Biology The College of William and Mary ---------- Assistant Professor Shanta Hinton,Biology The College of William and Mary COMPLIANCE PAGE Research approved by Steve Kaattari Protocol number(s): IBC-2012-10-08-8156-opkers Date(s) of approval: 2013-11-02 ABSTRACT Posttranslational modification by the Small Ubiquitin-like Modifier (SUMO) is a pervasive mechanism for controlling protein function.
    [Show full text]
  • Chaperonin Function: Folding by Forced Unfolding
    R EPORTS (1985); N. Romani et al., ibid. 169, 1169 (1989); C. migrated was measured with the clonotypic antibody 26. J. G. Cyster, J. Exp. Med. 189, 447 (1999). Heufler et al., ibid. 176, 1221 (1992). to TCR KJ1-26 (28). Overnight incubation of day 2 27. G. G. MacPherson, C. D. Jenkins, M. J. Stein, C. Ed- 23. R. Bonecchi et al., ibid. 187, 129 (1998). draining lymph node cells (at 107 cells/ml) in medium wards, J. Immunol. 154, 1317 (1995). 24. Anti-OVA (DO11.10) T cell receptor (TCR) transgenic containing interleukin-2 (IL-2) (4 ng/ml) increased 28. K. Haskins et al., J. Exp. Med. 157, 1149 (1983). 1 lymph node cells (5 3 106 cells) were transferred to the sensitivity of activated KJ1-26 cells to MDC 29. We thank R. Locksley, S. Luther, K. Reif, and A. Weiss for comments on the manuscript; M. Ansel for help BALB/c mice that were immunized 1 day later with (14). Therefore, IL-2–cultured cells were used in ex- with the in vivo transfer experiments; and C. 100-mg OVA in Freund’s complete adjuvant (25). periments to detect chemokine production by puri- McArthur for cell sorting. Supported in part by NIH fied lymph node DCs and stromal cells. Draining (pool of brachial, axillary, and inguinal) and grant AI-40098, the Pew Foundation (J.G.C.), and the nondraining (mesenteric) lymph node cells were iso- 25. E. R. Kearney, K. A. Pape, D. Y. Loh, M. K. Jenkins, American Lung Association (H.L.T.). lated 1 to 5 days later and used in MDC chemotaxis Immunity 1, 327 (1994); K.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • UBA2 Activates Wnt/ Β-Catenin Signaling Pathway
    UBA2 Activates Wnt/ β-catenin Signaling Pathway during Protection of R28 Retinal Precursor Cells from Hypoxia by Extracellular Vesicles derived from Placental Mesenchymal Stem Cells Kyungmin Koh CHA University Mira Park CHA University Eun Soo Bae CHA University Van-An Duong Gachon University Jong-Moon Park Gachon University Hookeun Lee Gachon University Helen Lew ( [email protected] ) CHA university https://orcid.org/0000-0003-0121-3000 Research Keywords: Exosome, hPMSCs, Optic nerve injury, Retinal precursor cells, UBA2, Wnt/β-catenin DOI: https://doi.org/10.21203/rs.3.rs-33694/v3 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/23 Abstract Background: Stem cell transplantation has been proposed as an alternative treatment for intractable optic nerve disorders characterized by irrecoverable loss of cells. Mesenchymal stem cells, with varying tissue regeneration and recovery capabilities, are being considered for potential cell therapies. To overcome the limitations of cell therapy, we isolated exosomes from human placenta–derived mesenchymal stem cells (hPMSCs), and investigated their therapeutic effects in R28 cells (retinal precursor cells) exposed to CoCl2. Method: After nine hours of exposure to CoCl2, the hypoxic damaged R28 cells were divided into non treatment group (CoCl2+R28 cells) and treatment group (CoCl2+R28 cells treated with exosome). Immunoblot analysis was performed for Pcna, Hif-1α, Vegf, Vimentin, Thy-1, Gap43, Ermn, Neuro≈ament, Wnt3a, β-catenin, phospo-GSK3β, Lef-1, UBA2, Skp1, βTrcp, and ubiquitin. The proteomes of each group were analyzed by liquid chromatography/tandem mass (LC-MS/MS) spectrometry. Differentially expressed proteins (DEPs) were detected by label-free quantiƒcation and the interactions of the proteins were examined through signal transduction pathway and gene ontology analysis.
    [Show full text]
  • Role of Ubiquitin-Specific Protease 25 in The
    ROLE OF UBIQUITIN-SPECIFIC PROTEASE 25 IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE IN DOWN SYNDROME by Beibei Song B.Sc., Memorial University, 2013 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENT FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Neuroscience) THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver) August 2018 © Beibei Song, 2018 The following individuals certify that they have read, and recommend to the Faculty of Graduate and Postdoctoral Studies for acceptance, the dissertation entitled: Role of USP25 in the Pathogenesis of Alzheimer’s Disease in Down Syndrome submitted by Beibei Song in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Neuroscience Examining Committee: Weihong Song Supervisor Yutian Wang Supervisory Committee Member Xin-Ming, Li External Examiner Honglin Luo University Examiner Christian Kastrup University Examiner Additional Supervisory Committee Members: Ann Marie Craig Supervisory Committee Member Jason Snyder Supervisory Committee Member ii Abstract Down syndrome (DS) is the most common genetic cause of intellectual disabilities. Trisomy 21, an extra copy of human chromosome 21, causes the majority of DS cases. After middle age, individuals with DS inevitably develop Alzheimer’s disease, the most common form of neurodegenerative diseases characterized by extracellular amyloid plaque deposition, intracellular neuritic fibrillary tangles and neuronal loss. The extracellular amyloid plaques are made of amyloid β (Aβ) proteins derived from β- and γ- cleavage of amyloid precursor protein (APP). The abnormal accumulation of Aβ proteins plays an essential role in AD pathogenesis. Ubiquitin-specific protease 25 (USP25) is a deubiquitinating enzyme that locates in the DS critical region of human chromosome 21.
    [Show full text]
  • Chaperonin-Assisted Protein Folding: a Chronologue
    Quarterly Reviews of Chaperonin-assisted protein folding: Biophysics a chronologue cambridge.org/qrb Arthur L. Horwich1,2 and Wayne A. Fenton2 1Howard Hughes Medical Institute, Yale School of Medicine, Boyer Center, 295 Congress Avenue, New Haven, CT 06510, USA and 2Department of Genetics, Yale School of Medicine, Boyer Center, 295 Congress Avenue, New Invited Review Haven, CT 06510, USA Cite this article: Horwich AL, Fenton WA (2020). Chaperonin-assisted protein folding: a Abstract chronologue. Quarterly Reviews of Biophysics This chronologue seeks to document the discovery and development of an understanding of – 53, e4, 1 127. https://doi.org/10.1017/ oligomeric ring protein assemblies known as chaperonins that assist protein folding in the cell. S0033583519000143 It provides detail regarding genetic, physiologic, biochemical, and biophysical studies of these Received: 16 August 2019 ATP-utilizing machines from both in vivo and in vitro observations. The chronologue is orga- Revised: 21 November 2019 nized into various topics of physiology and mechanism, for each of which a chronologic order Accepted: 26 November 2019 is generally followed. The text is liberally illustrated to provide firsthand inspection of the key Key words: pieces of experimental data that propelled this field. Because of the length and depth of this Chaperonin; GroEL; GroES; Hsp60; protein piece, the use of the outline as a guide for selected reading is encouraged, but it should also be folding of help in pursuing the text in direct order. Author for correspondence: Arthur L. Horwich, E-mail: [email protected] Table of contents I. Foundational discovery of Anfinsen and coworkers – the amino acid sequence of a polypeptide contains all of the information required for folding to the native state 7 II.
    [Show full text]
  • Insights Into the Role and Mechanism of the AAA+ Adaptor Clps
    Insights into the role and mechanism of the AAA+ adaptor ClpS by Jennifer Yuan Hou Sc.B. Biochemistry Brown University, 2002 SUBMITTED TO THE DEPARTMENT OF BIOLOGY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY JUNE 2009 © 2009 Jennifer Yuan Hou. All Rights Reserved. The author hereby grants to MIT permission to reproduce and to distribute publicly paper and electronic copies of this thesis document in whole or in part in any medium now known or hereafter created. Signature of Author:_______________________________________________________ Department of Biology May 22, 2009 Certified by:_____________________________________________________________ Tania A. Baker E. C. Whitehead Professor of Biology Thesis Supervisor Accepted by:_____________________________________________________________ Stephen P. Bell Professor of Biology Co-Chair, Graduate Committee 1 2 Insights into the role and mechanism of the AAA+ adaptor ClpS by Jennifer Yuan Hou Submitted to the Department of Biology on May 22, 2009 in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy at the Massachusetts Institute of Technology ABSTRACT Protein degradation is a vital process in cells for quality control and participation in regulatory pathways. Intracellular ATP-dependent proteases are responsible for regulated degradation and are highly controlled in their function, especially with respect to substrate selectivity. Adaptor proteins that can associate with the proteases add an additional layer of control to substrate selection. Thus, understanding the mechanism and role of adaptor proteins is a critical component to understanding how proteases choose their substrates. In this thesis, I examine the role of the intracellular protease ClpAP and its adaptor ClpS in Escherichia coli.
    [Show full text]
  • UBA2 Promotes Proliferation of Colorectal Cancer
    5552 MOLECULAR MEDICINE REPORTS 18: 5552-5562, 2018 UBA2 promotes proliferation of colorectal cancer PING HE1, XUN SUN2, HONG-JING CHENG1, YA‑BIN ZOU2, QUAN WANG3, CHANG‑LI ZHOU1, WAN-QI LIU1, YUE-MING HAO1 and XIANG-WEI MENG1 Departments of 1Gastroenterology, 2Pathology and 3Gastrointestinal Surgery, Bethune First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China Received December 18, 2017; Accepted August 13, 2018 DOI: 10.3892/mmr.2018.9613 Abstract. Small ubiquitin‑like modifier proteins are involved Introduction in tumorigenesis; however, the potential effects and func- tions of the family member ubiquitin‑like modifier‑activating Colorectal cancer is the third most common cancer world- enzyme 2 (UBA2) on colorectal cancer are not clear. The wide (1); the lifetime risk of developing colorectal cancer is present study aimed to examine the effects of UBA2 on the 4.7% for men and 4.4% for women. Although the mortality proliferation of colorectal cancer cells in vitro and in vivo. The rate from colorectal cancer has been declining for several mRNA and protein expression levels of UBA2 in patients with decades owing to the early diagnosis and improved treatment, colorectal cancer were measured by reverse transcription‑quan- >1 million novel cases are diagnosed each year. Therefore, it titative polymerase chain reaction and immunohistochemistry, is crucial to identify novel biomarkers and therapeutic targets respectively. UBA2 expression levels in colorectal cancer for colorectal cancer to improve the prognosis of the disease. tissues were significantly increased compared with the para- Sumoylation is a transient post‑translational modifica- cancerous normal tissues. The expression of UBA2 was also tion process that is highly regulated by the balance between associated with higher stage colorectal cancer and poor prog- enzyme‑mediated conjugating and deconjugating activities.
    [Show full text]
  • Ubiquitin-Dependent Regulation of the WNT Cargo Protein EVI/WLS Handelt Es Sich Um Meine Eigenständig Erbrachte Leistung
    DISSERTATION submitted to the Combined Faculty of Natural Sciences and Mathematics of the Ruperto-Carola University of Heidelberg, Germany for the degree of Doctor of Natural Sciences presented by Lucie Magdalena Wolf, M.Sc. born in Nuremberg, Germany Date of oral examination: 2nd February 2021 Ubiquitin-dependent regulation of the WNT cargo protein EVI/WLS Referees: Prof. Dr. Michael Boutros apl. Prof. Dr. Viktor Umansky If you don’t think you might, you won’t. Terry Pratchett This work was accomplished from August 2015 to November 2020 under the supervision of Prof. Dr. Michael Boutros in the Division of Signalling and Functional Genomics at the German Cancer Research Center (DKFZ), Heidelberg, Germany. Contents Contents ......................................................................................................................... ix 1 Abstract ....................................................................................................................xiii 1 Zusammenfassung .................................................................................................... xv 2 Introduction ................................................................................................................ 1 2.1 The WNT signalling pathways and cancer ........................................................................ 1 2.1.1 Intercellular communication ........................................................................................ 1 2.1.2 WNT ligands are conserved morphogens .................................................................
    [Show full text]